3 results
The objective is to assess the feasibility and safety of the Qvanteq*s bioactive coronary Qstent for treatment of stable coronary artery disease patients with de novo coronary artery stenosis in native vessels.
The primary objective is the Objective tumor response rate (RECIST). Secondary objectives are: duration of overall response, time to tumor progression (TTP), progression free survival (PFS), overall survival, toxicity profile, incidence of…
The aim of this study is to investigate whether postoperative ventilation with INTELLiVENT-ASV in high risk patients, after cardio-thoracic surgery, is as effective, more user-friendly and as safe as compared to the conventional modes of ventilation…